Gates Foundation logo
Grand Challenges

Grand Challenges — Placental and Gut Inflammation Interventions for Fetal Growth

Funds global teams developing drug, biologic, dietary, or microbiome-based interventions that target placental and gut inflammatory pathways to improve fetal growth outcomes in low-income countries.

ClosedGates FoundationGlobal

This Grand Challenge is run by the Gates Foundation under its Grand Challenges program. It funds interventions targeting the maternal gut-placenta inflammatory axis — a potential driver of fetal growth restriction (FGR) — which affects an estimated 23.4 million infants born growth-restricted each year, with 60–70% of cases in sub-Saharan Africa and South Asia. Three funding tracks cover the full i…

Drug-based, biologic, dietary, and microbiome-informed interventions targeting maternal gut-placenta inflammatory axes and oxidative stress during pregnancy. Three tracks: mechanism and target discovery (up to $400K), candidate validation and translational advancement (up to $750K), and early clinical proof-of-concept (up to $1M). Focus on global south pregnancy contexts.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.17 weeks
Project durationiHow long the funded work is expected to run.1–30 months
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →

More from Gates Foundation

All grants from this funder →
Gates Foundation logo
Between cycles

Gates Foundation Grand Challenges — Portfolio

Gates Foundation · United States

Supports global health innovators through rotating challenge themes in diagnostics, nutrition, and development-focused technologies for public impact.

BiotechMedtech+2
$1.5M
Gates Foundation logo
Closed

Estimating the Global Burden of Diarrheal Diseases

Gates Foundation · United States

Supports teams producing country-level estimates of major diarrheal diseases to inform global health planning and child health priorities.

BiotechMedtech
$1.5M
Gates Foundation logo
Closed

Grand Challenges — Breakthrough Innovations to Reduce the Cost of Severe Acute Malnutrition Treatment

Gates Foundation · United States

Funds global teams developing system-level innovations that reduce the total cost of treating severe acute malnutrition in Sub-Saharan Africa and South Asia.

MedtechAI+2
$1.5M
Gates Foundation logo
Closed

Grand Challenges — Cost-Reducing Innovations for Ready-to-Use Therapeutic Food

Gates Foundation · United States

Funds global teams developing innovations in protein, lipids, packaging, and manufacturing that reduce the ex-factory unit cost of ready-to-use therapeutic food by at least 30%.

Food TechAdvanced Manufacturing+3
$1.5M
Gates Foundation logo
Closed

Grand Challenges — Ultralow-Cost Diagnostics and Screening for Low-Income Countries

Gates Foundation · United States

Funds global teams developing diagnostic devices and screening tools that cost approximately $1 per test or near-zero incremental cost per person screened for deployment in low-income countries.

BiotechMedtech+6
$300K – $1M
Gates Foundation logo
Closed

Innovations in Low-Cost and Simplified Pathogen Sequencing Workflows

Gates Foundation · United States

Funds research teams building low-cost, simplified pathogen-sequencing workflows that bring the cost of sequencing a sample down to about US$1-10 for use in low- and middle-income countries.

Biotech
$300K – $800K